An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer

A J Munro, A J Munro

Abstract

Meta-analysis of the published results from 54 randomised controlled trials of adjuvant chemotherapy in head and neck cancer suggests that chemotherapy might increase absolute survival by 6.5% (95% confidence interval 3.1-9.9%). The odds ratio in favour of chemotherapy is 1.37 (95% confidence interval 1.24-1.5). Single-agent chemotherapy given synchronously with radiotherapy increased survival by 12.1% (95% confidence interval 5-19%). The benefit from neoadjuvant chemotherapy was less: a rate difference of 3.7% (95% confidence interval 0.9-6.5%). The results suggest that the investigation of optimal agents and scheduling for synchronous radiotherapy and chemotherapy might still be important in clinical trials in head and neck cancer.

References

    1. Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):85-9
    1. J Natl Cancer Inst. 1993 Jan 20;85(2):95-111
    1. Acta Oncol. 1989;28(1):61-5
    1. Acta Chir Belg. 1990 May-Jun;90(3):115-22
    1. AJR Am J Roentgenol. 1976 Feb;126(2):229-35
    1. Recent Results Cancer Res. 1978;68:309-17
    1. J Clin Oncol. 1987 Jan;5(1):10-20
    1. Clin Radiol. 1980 Sep;31(5):617-20
    1. Arch Otolaryngol Head Neck Surg. 1987 Jul;113(7):758-61
    1. J Clin Oncol. 1987 Feb;5(2):278-85
    1. Cancer. 1976 Jun;37(6):2703-8
    1. Clin Radiol. 1987 Nov;38(6):575-81
    1. N Engl J Med. 1992 Oct 15;327(16):1115-21
    1. J Clin Oncol. 1985 May;3(5):672-9
    1. Acta Oncol. 1988;27(2):131-46
    1. Int J Radiat Oncol Biol Phys. 1990 Dec;19(6):1347-50
    1. Arch Intern Med. 1985 Apr;145(4):709-12
    1. Cancer. 1963 Mar;16:355-63
    1. Semin Radiat Oncol. 1992 Jul;2(3):195-205
    1. Int J Radiat Oncol Biol Phys. 1992;23(3):483-9
    1. Control Clin Trials. 1986 Sep;7(3):177-88
    1. Am J Clin Oncol. 1985 Dec;8(6):490-6
    1. Cancer. 1974 Sep;34(3):491-6
    1. Int J Radiat Oncol Biol Phys. 1991 Feb;20(2):243-6
    1. J Clin Oncol. 1986 Jul;4(7):1121-6
    1. Am J Roentgenol Radium Ther Nucl Med. 1972 Jan;114(1):83-8
    1. Radiology. 1975 Sep;116(3):709-12
    1. Int J Radiat Oncol Biol Phys. 1993 Mar 15;25(4):613-8
    1. Med Pediatr Oncol. 1979;6(4):353-8
    1. Br J Cancer. 1990 May;61(5):779-87
    1. Lancet. 1993 Feb 13;341(8842):418-22
    1. Radiother Oncol. 1983 Nov;1(2):101-7
    1. Int J Radiat Oncol Biol Phys. 1992;23(4):705-13
    1. Clin Otolaryngol Allied Sci. 1989 Feb;14(1):17-22
    1. Cancer Surv. 1989;8(3):511-33
    1. Laryngoscope. 1988 Nov;98(11):1205-11
    1. Am J Roentgenol Radium Ther Nucl Med. 1969 Mar;105(3):555-65
    1. Cancer. 1981 May 1;47(9):2259-64
    1. Am J Roentgenol Radium Ther Nucl Med. 1968 Mar;102(3):530-40
    1. Neth J Med. 1985;28(9):347-51
    1. Otolaryngol Head Neck Surg. 1985 Dec;93(6):712-7
    1. J Clin Oncol. 1987 Sep;5(9):1410-8
    1. Radiology. 1966 Feb;86(2):247-50
    1. Med Pediatr Oncol. 1984;12(3):204-8
    1. Int J Radiat Oncol Biol Phys. 1990 Oct;19(4):973-5
    1. Prog Clin Cancer. 1975;6:79-86
    1. Int J Radiat Oncol Biol Phys. 1985 Nov;11(11):1877-86
    1. NCI Monogr. 1988;(6):275-8
    1. Int J Radiat Oncol Biol Phys. 1980 May;6(5):533-41
    1. N Engl J Med. 1992 Jul 23;327(4):248-54
    1. JAMA. 1992 Jul 8;268(2):240-8

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться